Long-term safety of icotinib in patients with non-small cell lung cancer: a retrospective, real-world study

BACKGROUND: Lung cancer is a global health problem with a high mortality, and the development of target therapy has led to a revolution in the treatment of lung cancer in recent years. Favorable efficacy and safety of icotinib have been demonstrated in patients with non-small cell lung cancer (NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen, Zhang, Yiping, Zhao, Qiong, Liu, Xiguang, Chen, Likun, Pan, Hongming, Li, Yuping, Lu, You, Huang, Jianjin, Zhang, Zhe, Du, Kaiqi, Zhang, Suning, Li, Tao, Lu, Liqin, Yu, Guangmao, Wang, Yang, Yuan, Xiaobin, Yang, Min, Ma, Yongbin, Tan, Fenlai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139014/
https://www.ncbi.nlm.nih.gov/pubmed/32274129
http://dx.doi.org/10.21037/jtd.2019.12.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139014/
https://www.ncbi.nlm.nih.gov/pubmed/32274129
http://dx.doi.org/10.21037/jtd.2019.12.115

Ejemplares similares